Global Markets
Home›Global Markets›Trade & Tariffs›Trump’s generic drug tariff plan raises questions on m…
Trump’s generic drug tariff plan raises questions on medicine prices
CNBC notes the details of the plan remain unclear, leaving uncertainty over which drugmakers could benefit or face higher costs.
CNBC Markets and CNBC World discuss a proposed tariff plan targeting generic drugs under a Trump proposal, and how the policy could affect medicine prices and supply chains.
The outlet says the concept raises questions about whether patients could see higher costs, which manufacturers could gain from the change, and how it might influence U.S. manufacturing of generic medicines.
CNBC also highlights that, as of now, key details are not fully spelled out, making it difficult to determine the likely winners and losers among drugmakers and suppliers.